…individual mechanism of action targeting the underlying disease pathology that causes gMG. The safety and efficacy of rozanolixizumab and zilucoplan have not been established and neither treatment is approved for…
Content Section:
News Posts
…research over thirty years ago which identified amyloid as important in the development of Alzheimer’s disease and has led to this moment today. “People affected by Alzheimer’s disease in the UK will…
Content Section:
News Posts
…amended to be patients with high disease activity despite full and adequate treatment (considered 12 months of treatment) with at least one disease modifying therapy, ie those who have had…
Content Section:
Articles
…European Commission. Upstaza is the first approved disease-modifying treatment for aromatic L-amino acid decarboxylase (AADC) deficiency and the first marketed gene therapy directly infused into the brain. It is approved…
Content Section:
News Posts
…traumatic brain disease, epilepsy, Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, stroke, prion disease, multiple sclerosis and amyotrophic lateral sclerosis are included in this book. Chapters on infectious and immune mediated…
Content Section:
Book Reviews
Neurocrine Biosciences has recently announced that its pipeline asset, Ingrezza (valbenazine), achieved the primary endpoint of reducing the symptoms of chorea (involuntary muscle movements) associated with Huntington’s disease (HD) in…
Content Section:
News Posts
‘Ketogenic diet and metabolic therapies: expanding roles in health and disease’ by Masino, presents a comprehensive review of this quickly developing area of nutrition and metabolism. The authors, world experts…
Content Section:
Book Reviews
25-28 July 2021, Lisboa, Portugal This conference will provide a unique forum for the research community focusing on translational studies geared towards therapies in AD and related neurodegenerative diseases to…
Content Section:
Event News
…to acquire up-to date information for improving their current practice. Autoimmune-mediated diseases affecting the peripheral nervous system (PNS) are a group of pathologies usually associated with an aggressive course and high …
Content Section:
Event News